You are here:
Select the mission or strategic goal page to track progress against its targets for the 2011-15 strategy:
International Finance Facility for Immunisation evaluation
GAVI second evaluation report
GAVI first evaluation report
From its inception in 2000 to 31 December 2013, GAVI has disbursed over US$6 billion to over 70 countries.
GAVI support: full listing of who gets what
For more detail, including a summary of GAVI's new strategy and business plan, success stories, facts and figures, country information and an overview of how the GAVI Alliance is governed, download the full report.
Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.
© GAVI Alliance 2014
modal window here